v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
Net sales $ 25,060 $ 15,732 $ 72,514 $ 76,067
Cost of sales 14,169 7,343 40,419 51,776
Gross profit 10,891 8,389 32,095 24,291
Operating expenses:        
Research and development 12,832 8,687 38,486 37,168
Selling, general, and administrative 9,748 8,443 33,152 27,736
Total operating expenses 22,580 17,130 71,638 64,904
Loss from operations (11,689) (8,741) (39,543) (40,613)
Other income, net 1,521 461 3,122 980
Loss before income taxes (10,168) (8,280) (36,421) (39,633)
Provision for income taxes 3 4 40 28
Net loss $ (10,171) $ (8,284) (36,461) (39,661)
Deemed dividends     0 (2,724)
Net loss attributable to common stockholders     $ (36,461) $ (42,385)
Net loss per share, basic $ (0.5) $ (18.96) $ (4.57) $ (113.5)
Net loss per share, diluted $ (0.5) $ (18.96) $ (4.57) $ (113.5)
Weighted-average shares used in computing net loss per share, basic 20,396,354 436,890 7,977,360 373,446
Weighted-average shares used in computing net loss per share, diluted 20,396,354 436,890 7,977,360 373,446
Comprehensive loss:        
Currency translation adjustment $ 65 $ (30) $ 80 $ 319
Comprehensive loss $ (10,106) $ (8,314) (36,381) (39,342)
Deemed dividends     0 (2,724)
Comprehensive loss attributable to common stockholders     $ (36,381) $ (42,066)